Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5

This publication has 25 references indexed in Scilit:

• Erythromycin Suppresses Interleukin 6 Expression by Human Bronchial Epithelial Cells: A Potential Mechanism of Its Anti-inflammatory Action
  Biochemical and Biophysical Research Communications, 1995
• The effects of glucocorticoids on human eosinophils
  Journal of Allergy and Clinical Immunology, 1994
• Methylxanthines and Calcium-Mobilizing Agents Inhibit the Expression of Cytokine-Inducible Nitric Oxide Synthase and Vascular Cell Adhesion Molecule-1 in Murine Microvascular Endothelial Cells
  Experimental Cell Research, 1994
• Anti-allergic activity of roxithromycin: Inhibition of interleukin-5 production from mouse T lymphocytes
  Life Sciences, 1993
• Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium.
  Journal of Clinical Investigation, 1991
• The eosinophil and bronchial asthma: Current understanding
  Journal of Allergy and Clinical Immunology, 1990
• Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.
  Journal of Clinical Investigation, 1988
• Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.
  The Journal of Experimental Medicine, 1988
• An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma
  Journal of Allergy and Clinical Immunology, 1986
• Inhibition of theophylline clearance by troleandomycin
  Journal of Allergy and Clinical Immunology, 1977